Glimepirida está indicado en el tratamiento de la diabetes mellitus tipo II, cuando la dieta, el ejercicio físico y la reducción de peso por sí solos no son adecuados. RS: EN-04757
We use our own and third-party cookies to ensure the functioning of our website. By clicking “Accept”, you agree that cookies are stored on your device to improve site navigation, analyze site usage, and collaborate with our marketing studies. You can also configure them. See Cookies Policy